首页> 美国卫生研究院文献>other >Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol
【2h】

Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol

机译:将药物干预整合到青少年多动症的行为治疗中的临床策略:药物整合方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Attention-Deficit/Hyperactivity Disorder (ADHD) is highly prevalent among adolescents enrolled in behavioral health services but remains undertreated in this age group. Also the first-line treatment for adolescent ADHD, stimulant medication, is underutilized in routine practice. This article briefly describes three behavioral interventions designed to promote stronger integration of medication interventions into treatment planning for adolescent ADHD: family ADHD psychoeducation, family-based medication decision-making, and behavior therapist leadership in coordinating medication integration. It then introduces the Medication Integration Protocol (MIP), which incorporates all three interventions into a five-task protocol: ADHD Assessment and Medication Consu ADHD Psychoeducation and Client Acceptance; ADHD Symptoms and Family Relations; ADHD Medication and Family Decision-Making; and Medication Management and Integration Planning. The article concludes by highlighting what behavior therapists should know about best practices for medication integration across diverse settings and populations: integrating medication interventions into primary care, managing medication priorities and polypharmacy issues for adolescents with multiple diagnoses, providing ADHD medications to adolescent substance users, and the compatibility of MIP intervention strategies with everyday practice conditions.
机译:注意缺陷/多动障碍(ADHD)在参加行为健康服务的青少年中高度流行,但在该年龄段仍未得到充分治疗。青春期多动症的一线治疗药物,刺激性药物,在常规实践中也未得到充分利用。本文简要介绍了三种旨在促进将药物干预措施更好地整合到青少年ADHD治疗计划中的行为干预措施:家庭ADHD心理教育,基于家庭的药物治疗决策以及行为治疗师在协调药物治疗整合方面的领导作用。然后,它介绍了药物整合协议(MIP),该协议将所有三种干预措施合并为一个五任务协议:ADHD评估和药物咨询;多动症心理教育和客户接受度;多动症的症状和家庭关系;多动症药物和家庭决策;以及药物管理和整合规划。本文的结尾部分着重强调了行为治疗师应该了解的各种环境和人群的药物整合最佳实践:将药物干预措施整合到初级保健中,为具有多重诊断的青少年管理药物优先级和多药问题,为青少年药物使用者提供ADHD药物,以及MIP干预策略与日常实践条件的兼容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号